INSPECS Group plc (AIM:SPEC)
London
· Delayed Price · Currency is GBP · Price in GBX 50.06
+1.06 (2.15%)
Mar 26, 2025, 11:04 AM GMT+1
INSPECS Group Market Cap
INSPECS Group has a market cap or net worth of 49.82 million as of March 26, 2025. Its market cap has decreased by -10.91% in one year.
Market Cap
49.82M
Enterprise Value
86.89M
Revenue
195.14M
Ranking
n/a
PE Ratio
n/a
Stock Price
50.06
Market Cap Chart
Since February 27, 2020, INSPECS Group's market cap has decreased from 137.95M to 49.82M, a decrease of -63.89%. That is a compound annual growth rate of -18.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2025 | 49.82M | 7.69% |
| Dec 31, 2024 | 46.26M | -45.83% |
| Dec 29, 2023 | 85.40M | 95.35% |
| Dec 30, 2022 | 43.72M | -88.33% |
| Dec 31, 2021 | 374.78M | 12.12% |
| Dec 31, 2020 | 334.26M | 142.30% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 177.58B |
| GSK plc | 60.54B |
| Haleon | 34.83B |
| Smith & Nephew | 9.43B |
| ConvaTec Group | 5.25B |
| Hikma Pharmaceuticals | 4.38B |
| HUTCHMED (China) | 1.99B |
| Genus | 1.28B |